Overview of Dr. Gutman
Dr. Jonathan Gutman is an oncologist in Aurora, CO and is affiliated with multiple hospitals in the area, including University of Colorado Hospital, UCHealth Memorial Hospital, and UCHealth Poudre Valley Hospital. He received his medical degree from New York University Grossman School of Medicine and has been in practice 15 years. He is one of 124 doctors at University of Colorado Hospital and one of 55 doctors at UCHealth Memorial Hospital who specialize in Oncology. He has more than 70 publications and over 500 citings.
Office
1665 Aurora Ct
Aurora, CO 80045Fax+1 720-848-1786- Is this information wrong?
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2006 - 2008
- University of ColoradoResidency, Internal Medicine, 2002 - 2005
- New York University School of MedicineClass of 2002
Certifications & Licensure
- CO State Medical License 2004 - 2025
- WA State Medical License 2006 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies Start of enrollment: 2006 Apr 01
- Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease Start of enrollment: 2005 Nov 18
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 2008 Jun 25
- Join now to see all
Publications & Presentations
PubMed
- Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving v...Minhajuddin, M., Stevens, B., Bosma, G., Abbott, D., Miltgen, N., Yuan, J., Treece, A., Jordan, C., Winters, A., Major, A., Siegele, B., Ewalt, M., Gutman, J., Pollyea...> ;Haematologica. 2023 Dec 14
- 1 citationsCytomegalovirus Immune reconstitution in cord blood transplant recipients on letermovir prophylaxis.Maheen Z Abidi, Kyle C Molina, Krystle Garth, Jonathan A Gutman, Adriana Weinberg> ;Transplant Infectious Disease. 2023 Oct 1
- 16 citationsVenetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse.Andrew Kent, Marc Schwartz, Christine McMahon, Maria Amaya, Clayton A Smith, Jennifer Tobin, Kelsey Marciano, Rebecca Rezac, Grace Bosma, Daniel A Pollyea, Jonathan A ...> ;Bone Marrow Transplantation. 2023 Aug 1
- Join now to see all
Journal Articles
- Venetoclax with Azacitidine Disrupts Energy Metabolism and Targets Leukemia Stem Cells in Patients with Acute Myeloid LeukemiaDaniel A Pollyea, Jonathan A Gutman, Enkhtsetseg Purev, Clayton Smith, Nature
Abstracts/Posters
- No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Com...Jonathan A Gutman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based TherapyJonathan A Gutman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Venetoclax and Azacitidine for Older Newly Diagnosed Patients with Acute Myeloid Leukemia: A Single-Institution Pilot Study Using Measurable Residual Disease to Guide ...Jonathan A Gutman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Re...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Tracking of AML-Associated Mutations Via Droplet Digital PCR Is Predictive of Outcomes Post-Transplant2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Cord Blood Outperforms Matched, Unrelated Donor in Bone Marrow TransplantJuly 26th, 2016
- Supporting a House Bill That Would Improve Access to Clinical Trials for EveryoneFebruary 16th, 2024
- Champions for Their Patients: 21 Inducted into CU Department of Medicine’s New Clinical Excellence SocietyFebruary 29th, 2024
Hospital Affiliations
- University of Colorado HospitalAurora, Colorado
- UCHealth Memorial HospitalColorado Springs, Colorado
- UCHealth Poudre Valley HospitalFort Collins, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: